Abstract
In contrast to adults, severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) usually leads to a mild illness in children. However, a few children have been reported to have severe manifestations including pneumonia, acute kidney injury, multi-organ failure and cardiac injury. This review focuses on cardiac involvement during SARS-CoV-2 infection and the recently described likely immune mediated post-COVID-19 syndrome. Therapeutic strategies for cardiac dysfunction in both these settings are briefly discussed.
Article PDF
Similar content being viewed by others
References
Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A Systematic Review [published online ahead of print, 2020 Apr 22]. JAMA Pediatr. 2020;https://doi.org/10.1001/jamapediatrics.2020.1467.
Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088–95.
Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan Li, et al. A 55-day-old female infant infected with 2019 novel coronavirus disease: Presenting with pneumonia, liver injury, and heart damage. J Infect Dis. 2020;221:1775–81.
Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units [published online ahead of print, 2020 May 11]. JAMA Pediatr. 2020;https://doi.org/10.1001/jamapediatrics.2020.1948.
Gefen AM, Palumbo N, Nathan SK, Singer PS, Castellanos-Reyes LJ, Sethna CB. Pediatric COVID-19-associated rhabdomyolysis: A case report. Pediatr Nephrol. 2020;35:1517–20.
Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Available from: https://emergency.cdc.gov/han/2020/han00432.asp. Accessed May 29, 2020
World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed May 29, 2020
Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14:247–50.
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1–6.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–10.
Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020;126:1443 55.
Giacomet V, Manfredini VA, Meraviglia G, Peri CF, Sala A, Longoni E, et al. Acute inflammation and elevated cardiac markers in a two-month-old infant with severe acute respiratory syndrome coronavirus 2 infection presenting with cardiac symptoms. Pediatr Infect Dis J. 2020;39:e149–51.
Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang F, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: A single centers observational study. World J Pediatr. 2020;16:251–9.
Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 2020; 55:1169 74.
Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. The different clinical characteristics of corona virus disease cases between children and their families in China — the character of children with COVID-19. Emerg Microbes Infect. 2020;9:707–13.
Samuel S, Friedman RA, Sharma C, Ganigara M, Mitchell E, Schleien C, et al. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR positive SARS-CoV-2 infection including drug induced changes in the corrected QT interval (QTc). Heart Rhythm. 2020;S1547–5271: 30632–9.
Oberweis ML, Codreanu A, Boehm W, Olivier D, Pierron C, Tsobo C, et al. Pediatric Life-threatening coronavirus disease 2019 with myocarditis. Pediatr Infect Dis J. 2020;39:e147–e149.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;e20200702.
Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr. 2020;179:1079–87.
Dhanalakshmi K, Venkataraman A, Balasubramanian S, Madhusudan M, Amperayani S, Putilibai S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome — temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children [published online ahead of print, 2020 Aug 6]. Indian Pediatr. 2020; S097475591600220.
Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic [published online ahead of print, 2020 May 17]. Circulation. 2020;https://doi.org/10.1161/CIRCULATIONAHA.120.048360.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–78.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyper inflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–8.
Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem inflammatory syndrome in children during the COVID-19 pandemic: A case series. J Pediatric Infect Dis Soc. 2020;9:393–8.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334–46.
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rawlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347–58.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [published online ahead of print, 2020 Jun 8]. JAMA. 2020;e2010369.
American College of Rheumatology. Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Available from: https://www.rheumatology.org/Portals/0/Files/ACR-COVID-19-Clinical-Guidance-Summary-MIS-C-Hyperinflammation.pdf. Accessed August 7, 2020.
Hassoun A, Thottacherry ED, Muklewicz J, Aziz QU, Edwards J. Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19. J Clin Virol. 2020;128:104443.
Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681–3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kohli, U., Lodha, R. Cardiac Involvement in Children With COVID-19. Indian Pediatr 57, 936–940 (2020). https://doi.org/10.1007/s13312-020-1998-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1998-0